Records containing: Influenza Infection

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2026-04-24
  Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza
• CLINICAL_TRIALS study record update · 2025-08-06
  A Phase 2a Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-4482 in Healthy Participants Inoculated With Experimental Influenza Virus
• CLINICAL_TRIALS study record update · 2025-05-31
  In-depth Analysis of the Immune Responses in the Upper Respiratory Tract in Older Adults Infected or Colonized With Streptococcus Pneumoniae (Spn)
• CLINICAL_TRIALS study record update · 2025-05-31
  In-depth Analysis of the Immune Responses in the Upper Respiratory Tract of Influenza-infected Children
• CLINICAL_TRIALS study record update · 2025-03-11
  Dose-Escalation Study of a Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2024-06-06
  Phase 1/2, Double-Blind, Placebo-Controlled, Dose Escalation and Expansion Study of ALVR106 in Addition to Standard of Care for the Treatment of High-Risk Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant
• CLINICAL_TRIALS study record update · 2022-04-29
  VRC 321: A Phase I Open-Label Clinical Trial to Evaluate Dose, Safety, Tolerability, and Immunogenicity of an Influenza H1 Stabilized Stem Ferritin Vaccine, VRCFLUNPF099-00-VP, in Healthy Adults
• CLINICAL_TRIALS study record update · 2020-07-09
  A Phase IIb Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Severe Influenza Infection
• CLINICAL_TRIALS study record update · 2018-12-26
  A Phase 2, Double-blind, Randomized Controlled Study to Evaluate Immunogenicity and Safety of Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult V Olunteers
• CLINICAL_TRIALS study record update · 2016-12-29
  A Randomized Double-Blind Parallel-Group Comparative Phase 2 Study to Evaluate the Immunogenicity and Safety of a Single Subcutaneous Injection of TAK-850 in Comparison With Influenza HA Vaccine in Healthy Adult Subjects
• CLINICAL_TRIALS study record update · 2016-04-07
  An Open-label, Multi-center, Phase 1/2 Study to Evaluate the Safety and Immunogenicity of an Intramuscular Injection of TAK-850 in Healthy Pediatric Subjects
• CLINICAL_TRIALS study record update · 2016-02-17
  A Randomized Double Blind Parallel-Group Comparative Phase 1/2 Study to Evaluate the Safety and Immunogenicity of a Single Subcutaneous Injection of TAK-850 in Healthy Adult Subjects
• CLINICAL_TRIALS study record update · 2014-09-23
  A Multicenter, Double-blind, Randomized, Escalating Dose-ranging Study to Investigate the Safety and Immunogenicity of the VAX102 Influenza Vaccine in Healthy Adults
• CLINICAL_TRIALS study record update · 2013-12-16
  Safety and Efficacy of Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination With the Novel Microneedle Delivery Device
• CLINICAL_TRIALS study record update · 2013-07-16
  A Randomized Controlled Study on the Effects of Tea Catechin Consumption on the Prevention of Influenza Infection in Healthy Adults
• CLINICAL_TRIALS study record update · 2013-02-15
  Effects of Gargling With Green Tea on Preventing Influenza Infection Among High School Students: A Randomized Clinical Study
• CLINICAL_TRIALS study record update · 2010-09-20
  Randomized, Open, Clinical Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine GC1116 With Adjuvant in Healthy Adults
• CLINICAL_TRIALS study record update · 2009-11-26
  The Effects of Tea Catechin Extracts Containing Mask on the Prevention of Influenza Infection
• CLINICAL_TRIALS study record update · 2009-11-05
  A Phase 1, Randomized, Controlled, Observer-Blinded, Dose Escalation Study of the Safety, Tolerability and Immunogenicity of a Single Dose of Adjuvanted Influenza Vaccine Combined With CpG7909 in Healthy Adults
• CLINICAL_TRIALS study record update · 2008-03-31
  Randomized Double-Blind Placebo Controlled Study Evaluating the Effect of Sublingual Administration of IFNa on the Immune Response to Influenza Vaccination in Subjects Aged 75 or More.
• CLINICAL_TRIALS study record update · 2006-10-31
  A Randomized Clinical Study of Catechin Gargling Effects on the Prevention of Influenza Infection